SITUATION: On 1 February, the Myanmar military seized control of the government, declaring a year-long state of emergency, following a general election in which Ms. Suu Kyi's National League for Democracy (NLD) party won by a landslide.
SITUATION: On 1 February, the Myanmar military seized control of the government, declaring a year-long state of emergency, following a general election in which Ms. Suu Kyi's National League for Democracy (NLD) party won by a landslide.
Johnson & Johnson's single-dose vaccine received Emergency Authorization Approval (EUA) from the U.S. Food and Drug Administration (FDA). In an effort to increase production, the Biden administration brokered a deal in which Merck would help manufacture J&J's vaccine.
INCIDENT: Members of Congress threatened due to January 6 violent attacks at the US Capitol Building
INCIDENT: Amid record-low temperatures, millions of Texas residents lost power and access to water, prompting the need for emergency assistance for Global Guardian clients and their employee base throughout the state.
The vaccination rollout continues to improve, with just over 1.3 million shots administered on average in the last seven days. This compares with just under one million doses administered per day on average two weeks ago. So far, around 27 million people have received at least one vaccine dose.
While new cases and hospitalizations have dropped and leveled off respectively over the past two weeks, daily deaths remain high, with the seven-day rolling average hovering above 3,000. The U.S. has now recorded over 406,000 deaths.
There are ongoing concerns of violent armed action across the U.S. following the storming of the U.S. Capitol Building on 06 January. Far-right extremists have called for "armed marches" from 16-20 January across the country.
© Copyright 2024 Global Guardian. All Rights Reserved. | Privacy Policy | Do Not Sell or Share My Personal Information | Privacy Rights Request Form | XML Sitemap | HTML Sitemap
Global Guardian needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.